Released on = July 19, 2007, 8:48 am

Press Release Author = Repromedix

Industry = Healthcare

Press Release Summary = Repromedix Appoints Dr. Michael J. Burns Chief Executive
Officer
National reproductive diagnostic laboratory positions for continued growth

Press Release Body = FOR IMMEDIATE RELEASE

Contact: Lisa Scimemi
Phone: 781-404-1752
Email: lscimemi@repromedix.com

Repromedix Appoints Dr. Michael J. Burns Chief Executive Officer
National reproductive diagnostic laboratory positions for continued growth

Woburn, MA, July 17, 2007 -Repromedix Corp., the leading national diagnostic
laboratory for advanced reproductive testing, announced today that Dr. Michael J.
Burns has been appointed Chief Executive Officer.

"We are delighted that we were able to attract Dr. Burns to Repromedix," said Jack
Davis, Chairman of the Board. With over 25-years experience growing international
pharmaceutical and healthcare companies, Dr. Burns brings extensive senior and
general management experience in the critical areas of medical research and
development, corporate and business development, product licensing and sales force
delivery and marketing."

Dr. Burns comes to Repromedix after having served more than ten years as the
President and Chief Operating Officer of Ferndale Laboratories, a leader in the
manufacturing and marketing of pharmaceutical products and medical devices. Having
joined Ferndale in 1992, Dr. Burns also served as the President of the company's
Pharmaceutical Division and Vice President of Corporate Development. Prior to
Ferndale, Dr. Burns held senior management and leadership positions with Yamanouchi
Europe B.V., Smith, Kline & French Pharmaceuticals Ltd., and Napp Laboratories Ltd.

"The increasing number of women seeking to have children later in life has
significantly contributed to the development of sophisticated and innovative
diagnostic techniques in reproductive medicine," said Paul Kowalski, President and
Vice President of Sales. "Repromedix has grown from a pioneer to national leader in
infertility diagnostics. We look forward to leveraging Dr. Burns' industry
experience and expertise as we continue to meet the growing need for valuable
medical and genetic information that can contribute to the attainment of parenthood
for so many."

"I couldn't be more excited to join the incredible team of infertility professionals
at Repromedix," said Dr. Michael J. Burns. "I am especially attracted to Repromedix'
decade-long passion for helping doctors help couples start families. I share deeply
the company's entrepreneurial spirit, its commitment to excellence and its vision
for future growth and medical partnership opportunities. I look forward to
contributing to the company's continued growth and success."

A British native, Dr. Burns holds a postgraduate degree in Pharmacology from the
University of Nottingham and an undergraduate degree from the University of Reading
in Physiology, Biochemistry and Chemistry.

About Repromedix (www.repromedix.com)

Repromedix is the leading national diagnostic laboratory for advanced reproductive
testing. By taking an interdisciplinary approach to clinical infertility testing
that encompasses endocrinology, immunology and genetics, Repromedix offers the most
comprehensive suite of advanced diagnostic tests that provide valuable information
regarding complex problems of reproductive failure. Since its inception in 1995,
the company has assisted more than 45,000 patients by conducting over 100,000
diagnostic tests for recurrent pregnancy loss, premature ovarian failure, male
infertility and unexplained infertility.


###


Web Site = http://www.repromedix.com

Contact Details = FOR IMMEDIATE RELEASE

Contact: Lisa Scimemi
Phone: 781-404-1752
Email: lscimemi@repromedix.com